EUVIMEDEUVIMED entdecken
Crossref

Modular synthesis of isoxazolopyrimidine derivatives with anti-SARS-CoV-2 activity

Hui Chen, Xin Wang, Lianyou Zheng, Lingling Shi, Zhaoliang Chen, Lei Zhang, Yan Zhang, Qiansong Gao, Jie Wang, Zhuoqi Zhang, Zhendong Guo, Jinbao Xiang

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Hui Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Combinatorial Chemistry and Drug Discovery of Jilin University, The School of Pharmaceutical Sciences, Jilin University, Changchun, Ji…. Hauptthemen laut MEDLINE: Pyrimidines, SARS-CoV-2, Antiviral Agents, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Jilin University, Fundamental Research Funds for the Central Universities, Fundamental Research Funds for Central Universities of the Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A highly efficient synthetic route for the preparation of isoxazolopyrimidine derivatives has been developed, characterized by mild reaction conditions, operational simplicity and high yields. Building on this, we further functionalized the isoxazolopyrimidine scaffold to synthesize 7-morpholinoisoxazolo[4,5-d]pyrimidine derivatives. In vitro evaluations revealed that compounds 5a and 6g demonstrated significant anti-SARS-CoV-2 activity. Mechanistic studies indicated that the antiviral effects of 5a and 6g were mediated through the inhibition of PI3Kδ kinase, highlighting their potential as targeted therapeutic agents. Moreover, in vivo experiments conducted in a golden hamster model demonstrated that compound 5a effectively suppressed SARS-CoV-2 replication in lung tissue, underscoring its therapeutic potential for combating COVID-19. These findings collectively suggest that isoxazolopyrimidine derivatives, particularly 5a, represent promising candidates for further development as anti-SARS-CoV-2 therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesSARS-CoV-2Antiviral AgentsCOVID-19 Drug TreatmentIsoxazolesAnimalsHumansStructure-Activity RelationshipMesocricetusVirus ReplicationMolecular StructureMicrobial Sensitivity TestsCOVID-19Dose-Response Relationship, DrugCricetinaeVero Cells

Stichwörter der Autor:innen

7-morpholinoisoxazolo[4,5-d]pyrimidine derivativesAnti-SARS-CoV-2 activityIsoxazolopyrimidinePI3Kδ inhibitor

Substanzen

PyrimidinesAntiviral AgentsIsoxazoles

Autor:innen und Institutionen

  • The Center for Combinatorial Chemistry and Drug Discovery of Jilin University, The School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, PR China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, 573 Tulip Street…
  • The Center for Combinatorial Chemistry and Drug Discovery of Jilin University, The School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, PR China. Electronic address: jbxiang@jlu.edu.cn.

Förderung

  • Jilin University
  • Fundamental Research Funds for the Central Universities
  • Fundamental Research Funds for Central Universities of the Central South University
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Wang, X., Zheng, L., Shi, L., Chen, Z., Zhang, L., Zhang, Y., Gao, Q., Wang, J., Zhang, Z., Guo, Z., & Xiang, J. (2025). Modular synthesis of isoxazolopyrimidine derivatives with anti-SARS-CoV-2 activity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108992

Vancouver

Chen H, Wang X, Zheng L, Shi L, Chen Z, Zhang L, et al. Modular synthesis of isoxazolopyrimidine derivatives with anti-SARS-CoV-2 activity. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108992

BibTeX
@article{Chen2025,
  author = {Chen, Hui and Wang, Xin and Zheng, Lianyou and Shi, Lingling and Chen, Zhaoliang and Zhang, Lei and Zhang, Yan and Gao, Qiansong and Wang, Jie and Zhang, Zhuoqi and Guo, Zhendong and Xiang, Jinbao},
  title = {Modular synthesis of isoxazolopyrimidine derivatives with anti-SARS-CoV-2 activity},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108992}
}
Kostenlos starten →